KRW 28400.0
(1.79%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 124.61 Billion KRW | 16.38% |
2022 | 107.07 Billion KRW | 34.55% |
2021 | 79.57 Billion KRW | -21.06% |
2020 | 100.8 Billion KRW | 176.47% |
2019 | 36.46 Billion KRW | 35.64% |
2018 | 26.88 Billion KRW | -25.45% |
2017 | 36.05 Billion KRW | 1.3% |
2016 | 35.59 Billion KRW | 0.0% |
2014 | 36.55 Billion KRW | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 121.84 Billion KRW | -2.22% |
2024 Q2 | 141.76 Billion KRW | 16.35% |
2023 Q4 | 124.61 Billion KRW | 24.31% |
2023 FY | 124.61 Billion KRW | 16.38% |
2023 Q1 | 90.99 Billion KRW | -15.01% |
2023 Q2 | 88.8 Billion KRW | -2.41% |
2023 Q3 | 100.24 Billion KRW | 12.88% |
2022 Q2 | 111.02 Billion KRW | 41.14% |
2022 Q1 | 78.66 Billion KRW | -1.14% |
2022 FY | 107.07 Billion KRW | 34.55% |
2022 Q4 | 107.07 Billion KRW | -0.35% |
2022 Q3 | 107.45 Billion KRW | -3.22% |
2021 Q2 | 70.67 Billion KRW | -30.55% |
2021 Q4 | 79.57 Billion KRW | 1.04% |
2021 Q1 | 101.75 Billion KRW | 2.13% |
2021 FY | 79.57 Billion KRW | -21.06% |
2021 Q3 | 78.75 Billion KRW | 11.44% |
2020 FY | 100.8 Billion KRW | 176.47% |
2020 Q4 | 99.63 Billion KRW | 47.06% |
2020 Q3 | 67.74 Billion KRW | -0.49% |
2020 Q2 | 68.08 Billion KRW | 88.98% |
2020 Q1 | 36.02 Billion KRW | 1.18% |
2019 FY | 36.46 Billion KRW | 35.64% |
2019 Q1 | 26.75 Billion KRW | -0.48% |
2019 Q4 | 35.6 Billion KRW | 16.12% |
2019 Q3 | 30.66 Billion KRW | 13.82% |
2019 Q2 | 26.94 Billion KRW | 0.71% |
2018 FY | 26.88 Billion KRW | -25.45% |
2018 Q3 | 20.52 Billion KRW | -21.82% |
2018 Q2 | 26.25 Billion KRW | 0.6% |
2018 Q4 | 26.88 Billion KRW | 30.97% |
2018 Q1 | 26.09 Billion KRW | -27.62% |
2017 Q2 | 35.2 Billion KRW | -14.25% |
2017 Q4 | 36.05 Billion KRW | -0.18% |
2017 FY | 36.05 Billion KRW | 1.3% |
2017 Q1 | 41.05 Billion KRW | 15.35% |
2017 Q3 | 36.11 Billion KRW | 2.6% |
2016 Q3 | 36.7 Billion KRW | 0.0% |
2016 Q4 | 35.59 Billion KRW | -3.03% |
2016 FY | 35.59 Billion KRW | 0.0% |
2014 FY | 36.55 Billion KRW | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
HLB Pharmaceutical Co., Ltd | 23.72 Billion KRW | -425.17% |
CMG Pharmaceutical Co., Ltd. | 19.74 Billion KRW | -531.155% |
Celltrion Pharm, Inc. | 162.52 Billion KRW | 23.329% |
Huons Global Co., Ltd. | 254.93 Billion KRW | 51.121% |
DongKook Pharmaceutical Co., Ltd. | 104.74 Billion KRW | -18.963% |
Enzychem Lifesciences Corporation | 5.65 Billion KRW | -2102.776% |
Humedix Co., Ltd. | 2.7 Billion KRW | -4512.235% |
Boditech Med Inc. | 10.56 Billion KRW | -1079.15% |
EuBiologics Co., Ltd. | 14.77 Billion KRW | -743.175% |
FutureChem Co.,Ltd | 3.68 Billion KRW | -3283.828% |
BNC Korea Co., Ltd. | 737.2 Million KRW | -16803.126% |
AptaBio Therapeutics Inc. | 13.93 Billion KRW | -794.29% |